Thus, TIPE3 enhances cellular resistance to colorectal cancer drugs by inhibiting the apoptosis of CRC cells, promoting autophagy, and alleviating drug-induced cellular injury. The gene discussed is TIPE3; the disease is colorectal carcinoma.